Shanghai Xuerong Biotechnology Co.,Ltd. (SHE:300511)

SHE:300511 Revenue

Shanghai Xuerong Biotechnology had revenue of 678.92M CNY in the quarter ending March 31, 2026, with 54.06% growth. This brings the company's revenue in the last twelve months to 2.23B, up 11.34% year-over-year. In the year 2025, Shanghai Xuerong Biotechnology had annual revenue of 1.99B, down -8.09%.

• Revenue (ttm): 2.23B
• Revenue Growth: +11.34%
• P/S Ratio: 2.31
• Revenue / Employee: 1.05M
• Employees: 2,112
• Market Cap: 5.15B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.99B	-174.83M	-8.09%
Dec 31, 2024	2.16B	-402.69M	-15.70%
Dec 31, 2023	2.57B	244.71M	10.55%
Jan 1, 2023	2.32B	247.30M	11.93%
Jan 1, 2022	2.07B	-129.06M	-5.86%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 4, 2026

Data Sources Report a data error